Ovzon AB (publ) (OVZON.ST)
SEK 16.62
(26.68%)
SEK 16.62
(26.68%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -14 Million | -112.15 Million | -75.92 Million | -153.7 Million | 9.62 Million | -60.44 Million |
| Net Income | -60 Million | -81.06 Million | -113.38 Million | -48.28 Million | 11.41 Million | -17.53 Million |
| Depreciation & Amortization | 28 Million | 23.38 Million | 9.89 Million | 6.37 Million | 18.77 Million | 6.22 Million |
| Deferred income taxes | - | - | - | -267 Thousand | -266 Thousand | - |
| Stock-based compensation | - | - | - | 267 Thousand | 266 Thousand | - |
| Change in working capital | 43 Million | -59.64 Million | 18.08 Million | -100.07 Million | -17.4 Million | -41.17 Million |
| Other non-cash items | -25 Million | 5.17 Million | 9.47 Million | -11.71 Million | -3.17 Million | -7.96 Million |
| Investing Cash Flow | -668 Million | -150.64 Million | -273.81 Million | -496.12 Million | -509.1 Million | -12.1 Million |
| Investments in PPE | -676 Million | -163.1 Million | -273.81 Million | -497.17 Million | -509.1 Million | -11.93 Million |
| Acquisitions | 8 Million | 12.45 Million | - | - | - | - |
| Investment purchases | - | - | - | - | - | -555 Thousand |
| Sales/Maturities of investments | - | - | - | 1.05 Million | - | 390 Thousand |
| Other Investing Activities | -1 Million | -22 Million | -2.61 Million | -20.33 Million | - | -165 Thousand |
| Financing Cash Flow | 651 Million | 101.51 Million | 558.62 Million | 581.79 Million | 654.94 Million | 90.49 Million |
| Debt repayment | -219 Million | -102.19 Million | -307.47 Million | -1.4 Million | -39.42 Million | -139.81 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 436 Million | 761 Thousand | 261.29 Million | 590.82 Million | 748.11 Million | 244.56 Million |
| Other Financing Activities | -4 Million | 202.94 Million | 604.8 Million | -7.62 Million | -53.74 Million | -14.25 Million |
| Accounts receivables | -58 Million | -1 Million | -39.31 Million | -25.29 Million | -64.87 Million | 6.5 Million |
| Accounts payables | 64 Million | -32.27 Million | 31.67 Million | -52.1 Million | 71.35 Million | -9.71 Million |
| Inventory | 13 Million | -28.66 Million | 9.42 Million | -22.26 Million | -24.65 Million | -5.29 Million |
| Other working capital | 24 Million | 2.29 Million | 16.29 Million | -413 Thousand | 768 Thousand | -35.88 Million |
| Cash at beginning of period | 275.61 Million | 406.08 Million | 185.02 Million | 257.38 Million | 77.16 Million | 49.67 Million |
| Cash at end of period | 247 Million | 275.61 Million | 406.08 Million | 185.02 Million | 257.38 Million | 77.16 Million |
| Capital Expenditure | -676 Million | -163.1 Million | -273.81 Million | -497.17 Million | -509.1 Million | -11.93 Million |
| Effect of forex changes on cash | 2 Million | 30.81 Million | 12.17 Million | -4.31 Million | 24.75 Million | 9.55 Million |
| Net cash flow / Change in cash | -28.61 Million | -130.47 Million | 221.05 Million | -72.35 Million | 180.21 Million | 27.49 Million |
| Free Cash Flow | -690 Million | -275.25 Million | -349.74 Million | -650.88 Million | -499.48 Million | -72.38 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -16 Million | -43 Million | 12 Million | -60 Million | -29 Million | -28 Million |
| Depreciation & Amortization | 6 Million | 7 Million | 8 Million | 28 Million | 7 Million | 7 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 16 Million | 19 Million | 19 Million | 43 Million | 4 Million | 11 Million |
| Other non-cash items | 69 Million | 62 Million | -29 Million | -25 Million | 6 Million | 10 Million |
| Investing Cash Flow | -49 Million | -74 Million | -279 Million | -668 Million | -42 Million | -230 Million |
| Investments in PPE | -49 Million | -76 Million | -280 Million | -676 Million | -42 Million | -236 Million |
| Acquisitions | - | 2 Million | - | 8 Million | - | 6 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -6 Million | -4 Million | 1 Million | -1 Million | -6 Million | -1 Million |
| Financing Cash Flow | -1 Million | - | 460 Million | 651 Million | -1 Million | -1 Million |
| Debt repayment | - | - | -219 Million | -219 Million | -1 Million | -1 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 243 Million | 436 Million | - | - |
| Other Financing Activities | -1 Million | - | -2 Million | -4 Million | -1 Million | -1 Million |
| Accounts receivables | -49 Million | 29 Million | -30 Million | -58 Million | 7 Million | -19 Million |
| Accounts payables | 6 Million | -53 Million | 33 Million | 64 Million | 7 Million | 17 Million |
| Inventory | -12 Million | -10 Million | 15 Million | 13 Million | 1 Million | -3 Million |
| Other working capital | 71 Million | 53 Million | 1 Million | 24 Million | -11 Million | 16 Million |
| Cash at beginning of period | 172 Million | 247 Million | 60 Million | 275.61 Million | 115 Million | 346 Million |
| Cash at end of period | 130 Million | 172 Million | 247 Million | 247 Million | 60 Million | 115 Million |
| Capital Expenditure | -49 Million | -76 Million | -280 Million | -676 Million | -42 Million | -236 Million |
| Effect of forex changes on cash | - | 2 Million | -4 Million | 2 Million | - | 8 Million |
| Net cash flow / Change in cash | -42 Million | -75 Million | 187 Million | -28.61 Million | -55 Million | -231 Million |
| Free Cash Flow | -41 Million | -79 Million | -270 Million | -690 Million | -54 Million | -243 Million |
0922
VLE
000908
BIOIF
ANRG
ZIMLAB